| 000 | 01906 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515152155.0 | ||
| 264 | 0 | _c20091008 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1879-0461 | ||
| 024 | 7 |
_a10.1016/j.critrevonc.2008.10.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPuthillath, Ajithkumar | |
| 245 | 0 | 0 |
_aA phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer. _h[electronic resource] |
| 260 |
_bCritical reviews in oncology/hematology _cSep 2009 |
||
| 300 |
_a242-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMashtare, Terry | |
| 700 | 1 | _aWilding, Gregory | |
| 700 | 1 | _aKhushalani, Nikhil | |
| 700 | 1 | _aSteinbrenner, Lynn | |
| 700 | 1 | _aRoss, Mary Ellen | |
| 700 | 1 | _aRomano, Karen | |
| 700 | 1 | _aWisniewski, Michelle | |
| 700 | 1 | _aFakih, Marwan G | |
| 773 | 0 |
_tCritical reviews in oncology/hematology _gvol. 71 _gno. 3 _gp. 242-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.critrevonc.2008.10.012 _zAvailable from publisher's website |
| 999 |
_c18533864 _d18533864 |
||